@EU_Startups
Revier Therapeutics, a Heidelberg-based #BioTech company advancing disease-modifying #therapies for patients with #cardiometabolic disease, has launched and closed a €6 million #Seed financing round. 🇩🇪🫀🧬💊

https://t.co/3QBkCY4tfE
3
Sona ulaştın 🎉

Çerezler bu web sitesini normal bir şekilde kullanmana ve bu web sitesindeki deneyimini kişiselleştirmene olanak sağlar.

>>Daha fazla bilgi